M Riggi
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
-
- Lung Cancer Research Studies
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 3
- Neutropenia and Cancer Infections 2
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 1
-
- Lung Cancer Treatments and Mutations 4
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Mario De Lena (1 shared paper)Marc-André Mahé (1 shared paper)P Hurteloup (2 shared papers)Jean‐Yves Douillard (2 shared papers)Rafael Rosell (2 shared papers)Penelope Brock (1 shared paper)Laurent Nguyen (1 shared paper)Ruth Ladenstein (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Journal of Thoracic Oncology (1 paper)European Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- FranceItalyUnited Kingdom
In The Last Decade
M Riggi
16 papers receiving 462 citations
Peers
Comparison fields: 5 of 46
- Pulmonary and Respiratory Medicine 288
- Oncology 107
- Hepatology 25
- Radiation 28
- Otorhinolaryngology 11
Countries citing papers authored by M Riggi
This map shows the geographic impact of M Riggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Riggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Riggi more than expected).
Fields of papers citing papers by M Riggi
This network shows the impact of papers produced by M Riggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Riggi. The network helps show where M Riggi may publish in the future.
Co-authors
The 25 scholars most cited alongside M Riggi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 262 | |
| 2 | 2012 | 51 | |
| 3 | 2008 | 42 | |
| 4 | Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model. | 1993 | 39 |
| 5 | 1999 | 26 | |
| 6 | 2008 | 17 | |
| 7 | 1995 | 9 | |
| 8 | 2019 | 8 | |
| 9 | 1991 | 8 | |
| 10 | 2000 | 4 | |
| 11 | 2006 | 4 | |
| 12 | 2013 | 1 | |
| 13 | 2019 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 1 | |
| 16 | [Rare case of chemodectoma with a rare mediastinal location]. | 1981 | 1 |
| 17 | 1991 | 0 |
About M Riggi
M Riggi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Surgery and Molecular Biology, having authored 17 papers that have together received 475 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Lung Cancer Research Studies (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Neutropenia and Cancer Infections (2 papers), CAR-T cell therapy research (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (288 citations), Oncology (107 citations), Hepatology (25 citations), Radiation (28 citations) and Otorhinolaryngology (11 citations). M Riggi has collaborated with scholars based in France, Italy and United Kingdom. Frequent co-authors include Mario De Lena, Marc-André Mahé, P Hurteloup, Jean‐Yves Douillard, Rafael Rosell, Penelope Brock, Laurent Nguyen, Ruth Ladenstein, Gilles Vassal and Gareth J. Veal. Their work appears in journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, Journal of Thoracic Oncology, European Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.